Starget Pharma Inc. — Form D
Starget Pharma Inc. of SHREVEPORT, LA, a company, filed a Form D exempt-offering notice with the SEC on 2026-02-03. The offering totals $22.2M, of which $16.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-02-03
- Form: D
- Accession: 0002108969-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $22.2M
- Amount sold: $16.4M
- Remaining: $5.8M
- Minimum investment: $50K
- Investors: 29
- Date of first sale: 2026-01-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-572220
Issuer
- Name: Starget Pharma Inc.
- CIK: 0002108969
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 2031 KINGS HIGHWAY, SHREVEPORT, LA, 71103
- Phone: 318-746-8430
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Ronen Kalmanson | Director | Ramat Hasharon, L3 |
| Sigal Kalmanson Cusnir | Executive Officer | Tzofit, L3 |
More